BodySpec has opened a retail DEXA scanning location in Oakland offering roughly 12-minute body composition scans for under $60, reporting fat mass, visceral fat, lean muscle and bone density. The company positions the service against the rapid uptake of GLP-1 receptor agonists, citing evidence that 25 to 40 percent of weight lost on these drugs can be lean tissue. Muscle and bone mass are established predictors of functional independence and mortality risk, yet have historically been measured only inside clinical settings.
Key Points
- DEXA scans under $60, approximately 12 minutes, retail storefront access
- GLP-1 weight loss may include 25–40 percent lean mass
- Scan reports visceral fat, lean muscle and bone density
Longevity Analysis
Scale weight conceals the variable that matters most for late-life function: whether tissue lost is adipose or contractile. Repeated body composition measurement converts an ambiguous signal into an interpretable one, allowing protein intake and resistance training to be adjusted while pharmacologic weight loss is underway, and flagging skeletal fragility in perimenopausal women before a fracture forces the diagnosis. The open question is adherence — measurement only alters outcomes when the data is acted on consistently over time, which the available material does not address.
Original published by Longevity.Technology, by Kyle Umipig.